收费全文 | 3665篇 |
免费 | 189篇 |
国内免费 | 24篇 |
耳鼻咽喉 | 77篇 |
儿科学 | 69篇 |
妇产科学 | 80篇 |
基础医学 | 472篇 |
口腔科学 | 67篇 |
临床医学 | 342篇 |
内科学 | 909篇 |
皮肤病学 | 24篇 |
神经病学 | 639篇 |
特种医学 | 118篇 |
外科学 | 387篇 |
综合类 | 8篇 |
一般理论 | 2篇 |
预防医学 | 167篇 |
眼科学 | 35篇 |
药学 | 214篇 |
中国医学 | 15篇 |
肿瘤学 | 253篇 |
2023年 | 26篇 |
2022年 | 55篇 |
2021年 | 91篇 |
2020年 | 60篇 |
2019年 | 83篇 |
2018年 | 102篇 |
2017年 | 74篇 |
2016年 | 109篇 |
2015年 | 100篇 |
2014年 | 148篇 |
2013年 | 182篇 |
2012年 | 276篇 |
2011年 | 241篇 |
2010年 | 152篇 |
2009年 | 144篇 |
2008年 | 251篇 |
2007年 | 247篇 |
2006年 | 240篇 |
2005年 | 254篇 |
2004年 | 223篇 |
2003年 | 196篇 |
2002年 | 194篇 |
2001年 | 33篇 |
2000年 | 19篇 |
1999年 | 27篇 |
1998年 | 56篇 |
1997年 | 30篇 |
1996年 | 16篇 |
1995年 | 32篇 |
1994年 | 19篇 |
1993年 | 19篇 |
1992年 | 15篇 |
1991年 | 9篇 |
1990年 | 16篇 |
1989年 | 12篇 |
1988年 | 8篇 |
1987年 | 10篇 |
1986年 | 11篇 |
1985年 | 12篇 |
1984年 | 13篇 |
1983年 | 7篇 |
1982年 | 15篇 |
1981年 | 5篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1976年 | 3篇 |
1974年 | 8篇 |
1973年 | 4篇 |
1970年 | 4篇 |
Background
Adenosine kinase deficiency is a recently described defect affecting methionine metabolism with a severe clinical phenotype comprising mainly neurological and hepatic impairment and dysmorphism.Methods
Clinical data of 11 additional patients from eight families with adenosine kinase deficiency were gathered through a retrospective questionnaire. Two liver biopsies of one patient were systematically evaluated.Results
The main clinical symptoms are mild to severe liver dysfunction with neonatal onset, muscular hypotonia, global developmental retardation and dysmorphism (especially frontal bossing). Hepatic involvement is not a constant finding. Most patients have epilepsy and recurrent hypoglycemia due to hyperinsulinism. Major biochemical findings are intermittent hypermethioninemia, increased S-adenosylmethionine and S-adenosylhomocysteine in plasma and increased adenosine in urine. S-adenosylmethionine and S-adenosylhomocysteine are the most reliable biochemical markers. The major histological finding was pronounced microvesicular hepatic steatosis. Therapeutic trials with a methionine restricted diet indicate a potential beneficial effect on biochemical and clinical parameters in four patients and hyperinsulinism was responsive to diazoxide in two patients.Conclusion
Adenosine kinase deficiency is a severe inborn error at the cross-road of methionine and adenosine metabolism that mainly causes dysmorphism, brain and liver symptoms, but also recurrent hypoglycemia. The clinical phenotype varies from an exclusively neurological to a multi-organ manifestation. Methionine-restricted diet should be considered as a therapeutic option.The liver contribution to the biological network underlying physical frailty in aging is underestimated. How best to measure this contribution magnitude and impact on health risk trajectories in frail individuals is not yet entirely clear. We analyzed the association of a novel liver frailty phenotype with the risk of death in older participants of the Salus in Apulia Study cohort. Clinical and physical examination, routine biomarkers, medical history, and anthropometry were analyzed in 1929 older adults (65?+). Physical frailty was classified by Cardiovascular Health Study criteria, and liver fibrosis risk by fibrosis-4 (FIB-4). The liver frailty phenotype was defined as physical frailty plus high-risk liver fibrosis (score?>?2.67). Physical frailty, high-risk liver fibrosis, and liver frailty subjects were compared to subjects without these conditions (non-frail). Proportional Cox regression tested the adjusted association between liver frailty and all-cause mortality for each category. The liver frailty prevalence was relatively low (3.8%), but higher in men (58.1%). Compared to non-frail older subjects, liver frailty subjects were significantly older (effect size (ES)???1.11, 95% confidence interval (CI)???1.35 to???0.87), with a lower education (ES 0.48, 95%CI 0.24 to 0.71) and higher multimorbidity (ES 15.81, 95%CI 4.20 to 27.41). Cox multivariate analyses showed a two-fold increased risk of overall mortality (hazard ratio 2.09, 95%CI 1.16–3.74) even after the adjustment for age, sex, education, and alcohol consumption. The liver frailty phenotype runs twice the risk of overall mortality compared with the non-frail population. This clinical tool, validated in a Southern Italian population, is based on simple sets of measures that can conveniently be assessed also in the primary care setting.
相似文献